Trial Profile
A phase IIa/b, randomised, double-blind, placebo-controlled, single-site, parallel group clinical trial to examine cannabidiol (CBD) as a pharmacological treatment for cannabis dependence in a young cannabis dependent population.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2020
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Drug dependence
- Focus Proof of concept; Therapeutic Use
- 30 Jul 2020 Status changed from recruiting to discontinued.
- 02 Jul 2014 New trial record